{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:24:02Z","timestamp":1750533842254,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08950"],"award-info":[{"award-number":["17K08950"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10147-019-01521-y","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T15:02:40Z","timestamp":1565622160000},"page":"210-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Detection of bacteria in blood circulation in patients receiving cancer chemotherapy"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5846-8202","authenticated-orcid":false,"given":"Akiko","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Shimokata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Mitsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Asahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"issue":"4","key":"1521_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ajh.10236","volume":"71","author":"K Tamura","year":"2002","unstructured":"Tamura K, Matsuoka H, Tsukada J et al (2002) Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study. Am J Hematol 71(4):248\u2013255","journal-title":"Am J Hematol"},{"issue":"2","key":"1521_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0924-8579(00)00241-7","volume":"16","author":"GP Bodey","year":"2000","unstructured":"Bodey GP (2000) Unusual presentations of infection in neutropenic patients. Int J Antimicrob Agents 16(2):93\u201395","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"1521_CR3","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1086\/383046","volume":"39","author":"K Tamura","year":"2004","unstructured":"Tamura K, Imajo K, Akiyama N et al (2004) Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia. Clin Infect Dis 39(Suppl 1):S15\u2013S24","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1521_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijc.11196","volume":"107","author":"E Tsuji","year":"2003","unstructured":"Tsuji E, Hiki N, Nomura S et al (2003) Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 107(2):303\u2013308","journal-title":"Int J Cancer"},{"issue":"7","key":"1521_CR5","doi-asserted-by":"publisher","first-page":"e68056","DOI":"10.1371\/journal.pone.0068056","volume":"8","author":"M Wong","year":"2013","unstructured":"Wong M, Barqasho B, Ohrmalm L et al (2013) Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia. PLoS ONE 8(7):e68056","journal-title":"PLoS ONE"},{"issue":"2","key":"1521_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1128\/IAI.23.2.403-411.1979","volume":"23","author":"RD Berg","year":"1979","unstructured":"Berg RD, Garlington AW (1979) Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23(2):403\u2013411","journal-title":"Infect Immun"},{"issue":"4","key":"1521_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bjh.13113","volume":"167","author":"WJ van der Velden","year":"2014","unstructured":"van der Velden WJ, Herbers AH, Netea MG et al (2014) Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol 167(4):441\u2013452","journal-title":"Br J Haematol"},{"issue":"3","key":"1521_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/107327480200900303","volume":"9","author":"E Chrischilles","year":"2002","unstructured":"Chrischilles E, Delgado DJ, Stolshek BS et al (2002) Impact of age and colony-stimulating factor use on hospital length of stay for febrile neutropenia in CHOP-treated non-Hodgkin's lymphoma. Cancer Control 9(3):203\u2013211","journal-title":"Cancer Control"},{"issue":"12","key":"1521_CR9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.6004\/jnccn.2017.0175","volume":"15","author":"J Crawford","year":"2017","unstructured":"Crawford J, Becker PS, Armitage JO et al (2017) Myeloid growth factors, version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 15(12):1520\u20131541","journal-title":"J Natl Compr Cancer Netw"},{"issue":"8","key":"1521_CR10","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2337\/dc13-2817","volume":"37","author":"J Sato","year":"2014","unstructured":"Sato J, Kanazawa A, Ikeda F et al (2014) Gut dysbiosis and detection of \"live gut bacteria\" in blood of Japanese patients with type 2 diabetes. Diabetes Care 37(8):2343\u20132350","journal-title":"Diabetes Care"},{"issue":"5","key":"1521_CR11","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1128\/JCM.01724-09","volume":"48","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Saito M, Tsuji H et al (2010) Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol 48(5):1624\u20131628","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1521_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1128\/AEM.01224-06","volume":"73","author":"K Matsuda","year":"2007","unstructured":"Matsuda K, Tsuji H, Asahara T et al (2007) Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 73(1):32\u201339","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"1521_CR13","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1128\/AEM.01843-08","volume":"75","author":"K Matsuda","year":"2009","unstructured":"Matsuda K, Tsuji H, Asahara T et al (2009) Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 75(7):1961\u20131969","journal-title":"Appl Environ Microbiol"},{"issue":"15","key":"1521_CR14","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1128\/AEM.07990-11","volume":"78","author":"K Matsuda","year":"2012","unstructured":"Matsuda K, Tsuji H, Asahara T et al (2012) Sensitive quantification of Clostridium difficile cells by reverse transcription-quantitative PCR targeting rRNA molecules. Appl Environ Microbiol 78(15):5111\u20135118","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"1521_CR15","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1128\/AEM.68.11.5445-5451.2002","volume":"68","author":"T Matsuki","year":"2002","unstructured":"Matsuki T, Watanabe K, Fujimoto J et al (2002) Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68(11):5445\u20135451","journal-title":"Appl Environ Microbiol"},{"issue":"12","key":"1521_CR16","doi-asserted-by":"publisher","first-page":"7220","DOI":"10.1128\/AEM.70.12.7220-7228.2004","volume":"70","author":"T Matsuki","year":"2004","unstructured":"Matsuki T, Watanabe K, Fujimoto J et al (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbilol 70(12):7220\u20137228","journal-title":"Appl Environ Microbilol"},{"issue":"2","key":"1521_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3412\/jsb.62.255","volume":"62","author":"T Matsuki","year":"2007","unstructured":"Matsuki T (2007) Development of quantitative PCR detection method with 16S rRNA gene-targeted genus- and species-specific primers for the analysis of human intestinal microflora and its application (in Japanese). Nihon Saikingaku Zasshi 62(2):255\u2013261","journal-title":"Nihon Saikingaku Zasshi"},{"issue":"5","key":"1521_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1348-0421.2002.tb02706.x","volume":"46","author":"E Kikuchi","year":"2002","unstructured":"Kikuchi E, Miyamoto Y, Narushima S et al (2002) Design of species-specific primers to identify 13 species of Clostridium harbored in human intestinal tracts. Microbiol Immunol 46(5):353\u2013358","journal-title":"Microbiol Immunol"},{"issue":"3","key":"1521_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/bjs.9385","volume":"101","author":"Y Yokoyama","year":"2014","unstructured":"Yokoyama Y, Nishigaki E, Abe T et al (2014) Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy. Br J Surg 101(3):189\u2013199","journal-title":"Br J Surg"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-019-01521-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:45:41Z","timestamp":1597103141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-019-01521-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s10147-019-01521-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"13 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Yuichi Ando received research funding from Yakult Honsha Co. The other authors have reported no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}